PROP1

Chr 5AR

PROP paired-like homeobox 1

Also known as: CPHD2, PROP-1

This gene encodes a paired-like homeodomain transcription factor required for normal pituitary development and expression of multiple pituitary hormones including growth hormone, prolactin, thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone. Biallelic mutations cause autosomal recessive combined pituitary hormone deficiency with deficiencies in multiple anterior pituitary hormones. The gene shows low constraint against loss-of-function variants in the general population (pLI 0.09, LOEUF 0.90).

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.901 OMIM phenotype
Clinical SummaryPROP1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.35) despite low pLI — interpret in context.
📋
ClinVar Variants
133 unique Pathogenic / Likely Pathogenic· 93 VUS of 400 total submissions
📖
GeneReview available — PROP1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.90LOEUF
pLI 0.088
Z-score 1.78
OE 0.35 (0.160.90)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.25Z-score
OE missense 0.94 (0.811.09)
130 obs / 138.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.35 (0.160.90)
00.351.4
Missense OE0.94 (0.811.09)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 3 / 8.6Missense obs/exp: 130 / 138.2Syn Z: -0.57
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePROP1-related combined pituitary hormone deficiencyLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7131th %ile
GOF
0.5170th %ile
LOF
0.49top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic62
Likely Pathogenic71
VUS93
Likely Benign139
Benign15
Conflicting19
62
Pathogenic
71
Likely Pathogenic
93
VUS
139
Likely Benign
15
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
17
3
42
0
62
Likely Pathogenic
31
36
4
0
71
VUS
2
65
22
4
93
Likely Benign
0
3
31
105
139
Benign
0
3
11
1
15
Conflicting
19
Total50110110110399

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PROP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Pituitary Hypoplasia.
Gangat M et al.·Endocrinol Metab Clin North Am
2017Review
Rathke's cleft cyst: From history to molecular genetics.
Hacioglu A et al.·Rev Endocr Metab Disord
2025Review
Genetic causes of isolated and combined pituitary hormone deficiency.
Giordano M·Best Pract Res Clin Endocrinol Metab
2016Review
Top 5 results · since 2015Search PubMed ↗